ArticleChemistry & biodiversity2026
Systems Pharmacology and Multitarget Modulation of Letrozole-HFD-Induced Polycystic Ovarian Syndrome by Fruit Pulp of Prunus armeniaca.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Systems Pharmacology and Multitarget Modulation of Letrozole-HFD-Induced Polycystic Ovarian Syndrome by Fruit Pulp of Prunus armeniaca.Chemistry & biodiversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine-metabolic disorder characterized by hyperandrogenism, insulin resistance, oxidative stress, and chronic inflammation. The present study investigated the multitarget pharmacological effects of hydroalcoholic extract of fruit pulp of Prunus armeniaca (HAE of FPPA) in a letrozole-high-fat diet (HFD)-induced PCOS model using integrated network pharmacology, ADMET profiling, molecular docking, and experimental validation. Intersection analysis identified 105 common targets between major FPPA phytoconstituents and PCOS-associated proteins, with enrichment of PI3K/Akt, MAPK, HIF-1, endocrine resistance, and inflammatory signaling pathways. Docking analysis demonstrated strong interactions of rutin, chlorogenic acid, and catechin with selected network-prioritized PCOS-associated proteins involved in insulin signaling, inflammation, and steroidogenesis. In vivo, HAE of FPPA dose-dependently restored estrous cyclicity, normalized LH/FSH ratio and testosterone levels, improved insulin resistance,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.